1 / 43

HYPERBILIRUBINEMIA IN TERM NEONATES

HYPERBILIRUBINEMIA IN TERM NEONATES. Tanya Oberoi Pandya D.O., M.B.A. & Vishaan Pandya (Master’s In Colic, PhD in Poopology). Definition. Infants >/= 35wks GA Total Serum Bilirubin >95th percentile for hours-of-age

Download Presentation

HYPERBILIRUBINEMIA IN TERM NEONATES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HYPERBILIRUBINEMIA IN TERM NEONATES Tanya Oberoi Pandya D.O., M.B.A. & Vishaan Pandya (Master’s In Colic, PhD in Poopology)

  2. Definition • Infants >/= 35wks GA Total Serum Bilirubin >95th percentile for hours-of-age • Up to 60% of term newborns have clinical jaundice in the first week of life

  3. Bilirubin • Final product of heme degredation • Insoluble in plasma (needs to be bound to albumin) • Has to go to liver to be conjugated • After liver, excreted in bile

  4. Risk Factors

  5. Why Neonates? :( • Newborn Bilirubin Production: 6 to 8 mg/kg/day • Adult Bilirubin Production: HALF that! • Newborn: • Relative polycythemia • Increased RBC turnover

  6. So What’s The Big Deal? KERNICTERUS!!!

  7. Kernicterus • Neurologic consequences of unconjugated bilirubin deposition in brain • Damage & scarring of basal ganglia & brain stem

  8. Kernicterus (Cont’d) • Unconjugated bilirubin > albumin binding capacity • Unconjugated bilirubin = Fat Soluble • Enters BBB • No specific level definitive for kernicturus • Be worried if Bilirubin level: • >25 in term baby WITHOUT hemolysis • >20 in term baby WITH hemolysis

  9. Kernicterus Signs

  10. Consequences of Kernicterus • Developmental delay • Motor delay • Sensorineural deafness • Mild mental retardation

  11. Classification

  12. 1 3

  13. Common Causes • Physiologic Jaundice • Breastfeeding Jaundice • Breastmilk Jaundice

  14. Physiologic Jaundice • Occurs: >24hours of life, drop by week 1 of life • Increased bilirubin load d/t relative polycythemia • Shortened erythrocyte life span (80 days compared with the adult 120 days) • Immature hepatic uptake and conjugation processes • Increased enterohepatic circulation

  15. Breastfeeding Jaundice • Occurs: 3-4 days of life • Due to insufficient milk production by mom or intake by baby; relative caloric deprivation in the first few days of life. • Decreased volume and frequency of feedings -->passive dehydration and the delayed passage of meconium

  16. Breastfeeding Jaundice Management • Increase frequency of feedings to more than 10 per day • Formula supplement if infant has decline in weight gain, delayed stooling, and continued poor caloric intake • Breastfeeding should be continued to maintain breast milk production • Supplemental water or dextrose-water administration should be avoided, as it decreases breast milk production and places the newborn at risk for iatrogenic hyponatremia

  17. BreastMILK Jaundice • Occurs later in life • Day 6 to 14 • Bili 12 to 20 • May stay high for 1-2 months

  18. BreastMILK Jaundice Etiology • Unclear • Substances in maternal milk, such as alpha glucuronidases, and nonesterified fatty acids, may inhibit normal bilirubin metabolism • The bilirubin level usually falls continually after infant is 2 weeks old, but it may remain persistently elevated for 1 to 3 months.

  19. BreastMILK Jaundice Management • Breastfeeding may be temporarily interrupted • Mother should continue to express breast milk to maintain production • With formula substitution, the total serum bilirubin level should decline rapidly over 48 hours,confirming the diagnosis • Breastfeeding may then be resumed.

  20. Pathologic Jaundice • Anything OTHER THAN physiologic or breastfeeding or breastmilk jaundice!!

  21. Pathologic Jaundice Features • Jaundice within 24 hours after birth • Rapidly rising total serum bilirubin concentration (increase of more than 5 per day), and a total serum bilirubin level higher than 17 in a full-term newborn • Other features of concern include prolonged jaundice • Evidence of underlying illness • Elevation of the serum conjugated bilirubin level to >2 mg per dL or more than 20% of the total serum bilirubin

  22. Pathologic Jaundice Causes • Sepsis • Rubella • Toxoplasmosis • Occult hemorrhage • Erythroblastosis fetalis.

  23. Pathologic Jaundice Workup • Fractionated serum bili (conjugated bili >2) • CBC with diff • Reticulocyte count • Blood type • Rh compatability • Coomb’s test • Peripheral blood smear • G6PD screen (if applicable) • Blood culture • UA, urine culture • TSH for hypothyroidism (on state screen) • Galactosemia (on state screen) • Cholestatic Jaundice (need to r/o biliary atresia if light colored stool, dark urine, urine with bilirubin, persistent jaundice >3wks)

  24. Hyperbilirubinemia Signs • Skin yellowing • Not visible if bili <4 • Estimate level by degree of icterus • Face 5; upper chest, 10; abdomen, 12; palms and soles, >15 [soles = 20] • Pallor, petechiae, extravasated blood, excessive bruising, hepatosplenomegaly, weight loss, and evidence of dehydration.

  25. Diagnosis • Jaundice in a term newborn fewer than 24 hours old is always pathologic • Based on rate of bilirubin level rise, risk of developing significant hyperbilirubinemia can be classified as low, intermediate, or high • If jaundice persists > 2 weeks in a formula-fed infant and >3 weeks in a breastfed infant, further evaluation is warranted

  26. Diagnosis (cont’d) • Laboratory studies: • Fractionated bilirubin level • Thyroid studies • Evaluations for metabolic disorders • Evaluation for hemolytic disease • Assessment for intestinal obstruction.

  27. Treatment • Phototherapy • Exchange Transfusion

  28. Phototherapy • Use blue wavelengths of light to alter unconjugated bilirubin in the skin. • Bilirubin converted to less toxic water-soluble photoisomers • Excreted in the bile and urine without conjugation

  29. 75th Percentile 40th Percentile

  30. When To Start Phototherapy? • TSB at 95th percentile • Although, may be facility dependent

  31. Phototherapy Optimization • Ideal configuration: 4 special blue bulbs (F20T12/BB) placed centrally, with two daylight fluorescent tubes on either side • Power output of the lights (irradiance) is directly related to the distance between the lights and the newborn • Ideal light distance: 15 to 20 cm from the infant • Naked • Eye shields • For double phototherapy: a fiber-optic pad can be placed under the newborn (twice as effective as standard phototherapy)

  32. Phototherapy Tid-Bits • If TSB levels approach or exceed the exchange transfusion line the sides of the bassinet, incubator, or warmer should be lined with aluminum foil or white material • If the total serum bilirubin does not decrease or continues to rise in an infant who is receiving intensive phototherapy, strongly suggests hemolysis • Infants who receive phototherapy and have an elevated conjugated bilirubin level (cholestatic jaundice) may develop the bronze-baby syndrome (brown discoloration)

  33. Phototherapy Cessation • Decline avg at 1-2 points within 4-6 hours • Decline may be slow in breastfed than in formula fed • Can be stopped if <15 • Turn off lights and check for rebound in ~12 hours • Avg rebound ~1 point • Hospital discharge does not have to be held for rebound elevation

  34. Phototherapy Complication • Burns • Dehydration • Retinal Damage • Thermoregulatory instability • Loose stools • Tanning of the skin

  35. Hydration Assessment • Percentage of birth weight lost • Mucous membranes • Fontanelle • Skin turgor

  36. Exchange Transfusion • Most rapid way of decreasing bilirubin • Removes partially hemolyzed and antibody-coated erythrocytes replacing them with uncoated donor RBCs that lack the sensitizing antigen

  37. Exchange Transfusion Indication • Hemolytic disease • Severe anemia • Rapid rise in TSB level (>1 mg per dL per hour in less than six hours) • Considered in nonhemolytics where intensive phototherapy fails • If the total serum bilirubin level remains elevated after intensive phototherapy • If the initial bilirubin level is meets defined critical levels based on the infant's age (approx >20-25)

  38. Exchange Therapy Complications • Air embolism • Vasospasm • Infarction • Infection • Death

  39. Monitoring • Recheck bilirubin level every 12-24 hours • Consider neonatologist consult if Bilirubin >20 or pathologic causes suspected

  40. Prevention • RhoGham in Rh negative moms • GA <12 weeks: 50mcg • GA >12 weeks: 300mcg • Universal Screening of ALL infants

  41. **Jaundice In Order**

  42. **Quickie on Phototherapy Number** • >15 at <24 • >18 at 25-48 • >20 at >48

More Related